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USING an in vitro autologous human system, the
immunomodulatory function of colonic intra-
epithelial lymphocytes (IEL) on cytokine produc-
tion by lamina propria mononuclear cells
(LPMNC) has been investigated. In contrast to
LPMNC, colonic IEL produced only low amounts
of IL-10, interferon-c and interleukin-2. However,
co-culture experiments (IEL+ LPMNC) have
shown that IEL can enhance the PHA-induced
synthesis of IL-2 and interferon-c, but not IL-10
by LPMNC. Using a transwell ￿ lter culture system
apparatus, this effect was shown not to require a
cell-to-cell interaction. Thus, IEL in vitro may
modulate the cytokine synthesis of LPMNC,
through the production of soluble factors. This
may prove highly relevant in the in vivo immune
activation of the gastrointestinal mucosa.
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Introduction
Because of their unique location within the
epithelium, their peculiar morphological and
phenotypic features (different from those of
peripheral blood and lamina propria lympho-
cytes) and their oligoclonal expression of ab T
cell receptors, many studies have focused on
IELfunction. Although their precise role in vivo
remains enigmatic, it has been shown in vitro
that, under certain conditions human IEL(hIEL)
exert various patterns of cytotoxicity, are cap-
able of proliferation, and perform some regula-
tory functions.1 9 It is believed that they may
interact with the adjacent epithelial cells and
underlying lamina propria cells. In particular,
we have previously shown that colonic hIEL
can inhibit the proliferation of autologous LPL.10
Moreover, hIEL were also able to suppress IgA
synthesis.11 Inhibitory mechanisms were shown
to occur through soluble factors, possibly cyto-
kines.
While some cytokines have a critical role in
inducing in￿ammation, others are crucial in
reducing in￿ammation and mediating the heal-
ing process. Most studies on murine IEL (mIEL)
have used lymphocytes from the small intestine.
Freshly isolated mIEL produce interferon-c, and
IL-5.12 Subsequently, it has been shown that
both TCR-ab and cd mIEL could produce
interferon-c, IL-2, IL-3 and IL-6 but not IL-4.13,14
However, the amounts of cytokines released by
cd mIEL were much lower compared with ab
mIEL. In addition, culture supernatants from
anti-TCR antibody-activated cd or ab mIEL
trigger synthesis of TNF-a, TGF-b and GM-CSF
that in￿uence epithelial function.14 16 Murine
colonic IEL expressed similar levels of IL-1,
interferon-c and TNF-a mRNA, and signi￿cantly
more IL-2, IL-4, IL-5 and IL-10 mRNA when
compared with small intestine mIEL.17 Recently,
human IEL were analysed for cytokine mRNA
expression: freshly isolated hIEL expressed high
levels of IL-1b, IL-8, IL-2R and IFN-c mRNA, but
signi￿cantly less IL-1a, IL-6, IL-7, TNF-a and
TNF-b mRNA. After in vitro polyclonal activa-
tion with phytohaemagglutinin (PHA) and PMA,
IL-2 and IFN-c mRNA were signi￿cantly in-
creased, whereas IL-1 mRNA was signi￿cantly
decreased.18,19 Furthermore, hIEL can produce
small amounts of IL-2 and IFN-c in response to
PHAeven though there is little proliferation.1,6,20
The production of these cytokines by hIEL is
markedly increased by addition of sheep red
blood cells to PHA or after stimulation through
the CD2 molecule.1 In hIEL, PHA induced no IL-
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resulted in detectable IL-4.9,21
It is thus reasonable to consider the possib-
ility that IEL may in￿uence LPL function
through the secretion of soluble factors. There-
fore, colonic hIELwere tested for their ability to
produce IL-2, IFN-c and IL-10. Furthermore, the
putative immunoregulatory function of IEL on
cytokine secretion by autologous LPLwas exam-
ined.
Materials and Methods
Subjects
Normal mucosa from colonic specimens was
used from 10 control patients who were under-
going resection for a colonic carcinoma. The
specimens were taken at least 5 cm away from
any macroscopic lesion.
Isolation of mucosal lymphocytes
IEL were isolated as previously described.10
Brie￿y, to isolate colonic IEL, mucosal strips
were immersed in RPMI-supplemented with
fetal calf serum (FCS), antibiotics (gentamycin
50 mg/ml, penicillin 100 U/ml, streptomycin
100 mg/ml). The washed specimens were then
stirred in the same medium with the addition of
1 mM dithiothreitol (Sigma) for 10 min. After
further washing, they were then incubated with
calcium- and magnesium-free HBSS and
0.75 mMethylenediaminetetraacetate (EDTA) in
a shaking water bath at 378 C for three periods
of 30 min each at 140 oscillations per minute.
This step was repeated twice and the resulting
supernatants were stored overnight at 48 C.
Further puri￿cation was achieved by passing
this crude preparation down a glass wool
column. The ￿ltrate was then centrifuged at
800 g for 30 min through a discontinuous
44 67 5% Percoll bilayer. The IEL were recov-
ered from the interface. To isolate the lamina
propria mononuclear cells (LPMNC), the treated
tissue was submitted to three more 45-min
incubations with calcium- and magnesium-free
HBSS and 5 mMEDTA. The mucosal strips were
digested overnight at 378 C with 100 ml RPMI
1640 supplemented as above plus 30 mg Clos-
tridium histolyticum collagenase (Boehringer
Mannheim, Germany). The digestate was passed
through a 100 mm nylon mesh ￿lter. After
separation on Ficoll-paque gradient, the LPL
were washed and resuspended in RPMI-supple-
mented as above. The viability of the cells was
assessed using 0.1%trypan blue.
Preparation of cytokine-containing
cell culture supernatants
hIEL or LPMNC at a concentration of 1 3 106
were cultured in 1 ml aliquots in 24-well plates
with or without 10 mg/ml PHA for 72 h at 378 C
in 5% CO2. The supernatants were then har-
vested, centrifuged and passed through a
0.22 mm ￿lter and stored at 208 C for subse-
quent cytokine analysis.
In¯ uence of IEL on the cytokine
production by autologous LPL
LPMNC (106) were cultured with IEL (106) for
72 h with or without PHA (10 mg/ml) in 24-well
plates in a ￿nal volume of 1 ml at 378 C in 5%
CO2. The control cultures consisted of IEL or
LPMNC alone, with or without PHA. At the end
of the culture, the supernatants were harvested,
centrifuged, passed through a 0.22 mm ￿lter and
stored at 208 C for subsequent cytokine analy-
sis (IL-2, IFN-c and IL-10). In addition, IEL were
co-cultured with LPMNC in a Transwell appara-
tus (Costar Cambridge, MA) (6.5 mm diameter,
3 mm pore size) which physically separated IEL
from LPMNC. The purpose of this series of
experiments was to investigate whether the
immunoregulatory function of IEL is mediated
by a soluble factor or requires interaction be-
tween IELand LPMNC.
Cytokine assays
Gamma-interferon, interleukin-10 (IL-10) and
interleukin-2 (IL-2) were measured by a sensi-
tive enzyme ampli￿ed immunoassay (Medgenix
Diagnostics, Fleurus, Belgium). Optical densities
were measured by an automated dual beam
ELISA reader at 450 nm for c-IFN, IL-10 and IL-2.
Concentrations of these cytokines were deter-
mined by reference to the serially diluted
standards included in each plate. The minimum
detectable concentrations of these assays were:
c-FN 0.03 IU/ml; IL-10 1 pg/ml; IL-2 0.1 IU/ml.
In these assays, duplicate values varied by , 5%
from their mean value.
Results
Cytokine production by colonic
mucosal lymphocytes
The median concentrations of cytokines se-
creted by IEL and LPMNC alone were respec-
tively 0.3 IU/ml (range 0± 0.6) and 1.5 IU/ml
(range 1± 8) for IFN-c, 1 IU/ml (range 0± 20) and
2.1 IU/ml (range 0.8± 2.4) for IL-2, 8 pg/ml
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L-10. Following stimulation with PHA, the
median IL-2 concentrations by control IEL and
LPMNCcultured alone were respectively 2.5 IU/
ml (range 1± 26) and 9 IU/ml (range 2± 450), the
median IFN-c levels were 27 IU/ml (range 1±
105) and 26.5 U/ml (range 2± 242), the median
IL-10 concentrations 3 pg/ml (range 1± 10) and
4 pg/ml (range 1± 100).
In¯ uence of IEL on the cytokine
production by autologous LPMNC
After 3 days of culture, the effect of IEL on
cytokine synthesis in co-culture with autologous
LPMNC was studied. Addition of 106 IEL only
minimally affected IL-10 production. The med-
ian secretion of IL-10 secreted by PHA-stimu-
lated LPMNC was 4 pg/ml (range 1± 100).
Following the addition of IEL, the concentra-
tions increased to 7.5 pg/ml (range 2± 340). In
contrast, they enhanced signi￿cantly the IL-2
and IFN-c production by LPMNC. After 3 days
of co-culture, IL-2 and IFN-c levels were respec-
tively 39.5 IU/ml (range 8± 450) and 104 IU/ml
(18± 500) (Figs 1, 2 and 3). Using the Transwell
culture apparatus, similar results were obtained
(T able 1).
Discussion
The present data con￿rm our previous work
showing that colonic IEL produce very low
amounts of interferon-c.20 Although there was a
signi￿cant increase in interferon-c production
following stimulation with PHA, the absolute
amounts of interferon-c were persistently low.
Sperber et al. reported similar ￿ndings using
IELstimulated with PHA or superantigens.9 This
was not due to the failure of lectin binding.22
The amount of interferon-c produced by stimu-
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FIG. 2. Interleukin-2 concentration (IU ml) secreted by PHA-
stimulated mucosal lymphocytes. IL-2 production by
LPMNC is signi® cantly affected by the addition of IEL.
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FIG. 1. Interleukin-10 concentration (pg ml) secreted by
PHA-stimulated mucosal lymphocytes IL-10 production by
LPMNC is minimally affected by the addition of IEL.
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FIG. 3. Interferon-gamma concentration (IU ml) secreted by
mucosal lymphocytes. IFN-gamma secretion by LPMNC is
signi® cantly increased by the addition of IEL.
Table 1. Cytokine production by PHA-stimulated mucosal
lymphocytes physically separated in a Transwell apparatus
IEL LPMNC PHA IEL LPMNC PHA
(transwell)
IL-10 (pg ml) 2.5 (2± 6.7) 1.9 (0.3± 4.6)
IL-2 (IU ml) 31.8 (7.8± 55.2) 18.4 (4.2± 70.8)
IFN-c (IU ml) 49 (18± 51) 90 (6.6± 158)
Median (range) cytokines production, n 5.
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IEL regulate cytokines secretion of LPMNClated hIEL was of suf￿cient quantity to induce
MHC class II expression molecules on HT -29
cells.20 Class II bearing epithelial cells can in
turn cause further activation of hIEL.23
IL-2 is a central regulator of immune and
in￿ammatory responses. It affects T cell prolif-
eration as well as B cells and the function of
macrophages, natural killer cells and lympho-
kine activated killer cell. PHA-stimulated colonic
hIEL produce similar low amounts of interleu-
kin-2, as do PHA-stimulated jejunal hIEL.6,20
Conversely, Sperber et al. showed that IL-2
production was not observed with PHA- or
superantigen-stimulated IEL.9 Interestingly, in-
duction of low levels of IL-2 does not correlate
with the induction of in vitro proliferation.
However, addition of exogeneous IL-2 does not
restore a normal proliferative response.6
IL-10 is a powerful suppressor of cytokines
produced by macrophages and Th2 subpopula-
tions of CD4 T cells.24 In addition, IL-10
inhibits antigen presentation but supports B cell
differentiation and IgA secretion.25,26 To the best
of our knowledge, this is the ￿rst observation
that human colonic IEL produce small amounts
of IL-10 (as do colonic lamina propria cells).
However, the precise action of this cytokine in
the intestinal mucosa remains to be de￿ned
although a colitis occurs in mice in which there
has been targeted deletion of the IL-10 gene.27
T eitelbaum et al. have shown that neutralizing
antibody to IL-10 did not block the inhibitory
activity of rat intestinal intraepithelial lympho-
cytes on the proliferative response of allogeneic
spleen-thymus cells stimulated with concacana-
valin A.15
Murine helper T cells can be classi￿ed in
relation to their cytokine production pro￿le.
Thus, Th1 cells produce large quantities of IL-2,
IFN-c and TNF-b while Th2 cells produce
preferentially IL-4, IL-5, IL-6 and IL-10.24 It has
been suggested that a subset of murine CD8 IEL
can produce some type 1 and 2 cytokines.12,13
Furthermore, it has been shown that some
human CD8 clones may secrete both patterns
of cytokines.28,29 It thus appears that these two
subsets (Th1 and Th2) are mutually antagonis-
tic. Th1 cells may in￿uence Th2 cell function
through these cytokines and vice versa. For
example, interferon-c may be able to down-
regulate a Th2 response while IL-10 has power-
ful inhibitory effects of the synthesis of Th1
cytokines.
The crucial role of cytokines in the mucosal
response is well illustrated by a number of
animal models of in￿ammatory bowel disease.
IL-2-, IL-10 and TGF-b1 knockout mice develop
chronic intestinal in￿ammation.27,30,31 The local
functions of these cytokines secreted by colonic
hIEL have not been fully investigated. The data
presented in this paper indicate that colonic
hIEL can enhance the PHA-induced synthesis of
IL-2 and interferon-c by human colonic LPMNC.
The upregulated LPMNC cytokine synthesis in
hIEL LPMNC co-cultures revealed that IEL did
not contain cells inhibiting synthesis of these
cytokines. Furthermore, absolute amounts of IL-
10 produced by PHA-stimulated hIEL and
LPMNC cultured alone or in co-culture were
persistently low. Thus, the increased release of
the Th1-cytokines may prove of importance in
the modulation of subsequent immunopatholo-
gical reactions including both activation of
in￿ammatory cells and expression of class II
molecules on epithelial cells.
Additional work must be done to understand
the hIEL inhibitory activity previously
described.10,11 As IL-4 is virtually not produced
by hIEL, further studies must be done in order
to determine other inhibitory cytokines pro-
duced by IELsuch as TGF-b and other inhibitory
factors (e.g. neuropeptides).
It is important to note that cytokines and
neuropeptides might in turn in￿uence hIEL
function. It has been suggested that interleukin-
7 (IL-7) might be produced in the mucosa by
intestinal epithelial cells, especially globlet
cells.8 Interleukin-7 is a B- and T -cell growth
factor. It affects the proliferation of activated
but not unstimulated human T cells. Recent
reports have shown that IL-7 stimulates hIEL
proliferation.7,8 In contrast, IL-9 or IL-12 did not
stimulate the proliferation of IEL.7 IL-4 secreted
by activated lamina propria cells suppresses IEL
proliferation and LAK activity.21 Finally two
neuropeptides, substance P and vasoactive in-
testinal peptide induce no proliferation nor
spontaneous cytotoxicity by hIEL. This was due
to an absence of substance P and vasoactive
intestinal peptide receptors.32,33
In conclusion, human colonic IEL may in￿u-
ence the cytokines produced by LPMNC. This
in vitro observation may be of importance in
the local in vivo immune activation of the
gastrointestinal tract.
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